Net Cash outflows from operating activities totaled $2.234 million for the September Quarter with the major cost components continuing to be external Research and Development expenditure and staff costs.
so is company not capable of R&D? - what do they need to pay external R&D for - anyone got any ideas?.
Estimated quarters of funding available (item 8.4 divided byitem 8.1) 0.6 - so CR well on the cards notwithstanding the "top up" received in October - well im not dipping in for this mob unless they change those at the top as they have had long enough to perform and yet not much has changed imo.
been relying on r&d rebate for far too long imo.
change those in charge only way IMO to get ahead!
Add to My Watchlist
What is My Watchlist?
